Tumor Immunology and Tumor Evolution: Intertwined Histories
- PMID: 31940273
- DOI: 10.1016/j.immuni.2019.12.018
Tumor Immunology and Tumor Evolution: Intertwined Histories
Abstract
Cancer is a complex disease whose outcome depends largely on the cross-talk between the tumor and its microenvironment. Here, we review the evolution of the field of tumor immunology and the advances, in lockstep, of our understanding of cancer as a disease. We discuss the involvement of different immune cells at distinct stages of tumor progression and how immune contexture determinants shaping tumor development are being exploited therapeutically. Current clinical stratification schemes focus on the tumor histopathology and the molecular characteristics of the tumor cell. We argue for the importance of revising these stratification systems to include immune parameters so as to address the immediate need for improved prognostic and/or predictive information to guide clinical decisions.
Keywords: T cells; adaptive immunity; immune contexture; immunoscore; immunotherapy; tumor microenvironment; tumor-immunology.
Copyright © 2020 Elsevier Inc. All rights reserved.
Similar articles
-
Human Anti-tumor Immunity: Insights from Immunotherapy Clinical Trials.Immunity. 2020 Jan 14;52(1):36-54. doi: 10.1016/j.immuni.2019.12.010. Immunity. 2020. PMID: 31940272 Review.
-
Understanding genetic determinants of resistance to immune checkpoint blockers.Semin Cancer Biol. 2020 Oct;65:123-139. doi: 10.1016/j.semcancer.2019.12.020. Epub 2019 Dec 24. Semin Cancer Biol. 2020. PMID: 31881338 Review.
-
Targeting the tumor microenvironment and T cell metabolism for effective cancer immunotherapy.Eur J Immunol. 2019 Aug;49(8):1147-1152. doi: 10.1002/eji.201848058. Epub 2019 Jul 9. Eur J Immunol. 2019. PMID: 31270810 Review.
-
Why is immunotherapy effective (or not) in patients with MSI/MMRD tumors?Bull Cancer. 2019 Feb;106(2):105-113. doi: 10.1016/j.bulcan.2018.08.007. Epub 2018 Oct 17. Bull Cancer. 2019. PMID: 30342749 Review.
-
Coinhibitory Pathways in Immunotherapy for Cancer.Annu Rev Immunol. 2016 May 20;34:539-73. doi: 10.1146/annurev-immunol-032414-112049. Epub 2016 Feb 25. Annu Rev Immunol. 2016. PMID: 26927206 Review.
Cited by
-
Tumor-derived extracellular vesicle proteins as new biomarkers and targets in precision oncology.J Mol Med (Berl). 2024 May 30. doi: 10.1007/s00109-024-02452-6. Online ahead of print. J Mol Med (Berl). 2024. PMID: 38814362 Review.
-
Role of Exosomes in Cancer and Aptamer-Modified Exosomes as a Promising Platform for Cancer Targeted Therapy.Biol Proced Online. 2024 May 27;26(1):15. doi: 10.1186/s12575-024-00245-2. Biol Proced Online. 2024. PMID: 38802766 Free PMC article. Review.
-
Microfluidic 3D Cytotoxic Assay.Methods Mol Biol. 2024;2804:209-221. doi: 10.1007/978-1-0716-3850-7_13. Methods Mol Biol. 2024. PMID: 38753150
-
Peptostreptococcus anaerobius mediates anti-PD1 therapy resistance and exacerbates colorectal cancer via myeloid-derived suppressor cells in mice.Nat Microbiol. 2024 Jun;9(6):1467-1482. doi: 10.1038/s41564-024-01695-w. Epub 2024 May 15. Nat Microbiol. 2024. PMID: 38750176 Free PMC article.
-
Digital Pathology for Better Clinical Practice.Cancers (Basel). 2024 Apr 26;16(9):1686. doi: 10.3390/cancers16091686. Cancers (Basel). 2024. PMID: 38730638 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials